Differences in cytokine responses to Onchocerca volvulus extract and recombinant Ov33 and Ovl3-1 proteins in exposed subjects with various parasitologic and clinical states

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 838-842

  Brattig, Norbert ^a   Nietz, Carola ^c   Hounkpatin, Sophie ^c   Lucius, Richard ^c   Seeber, Frank ^b   Pichlmeier, Uwe ^c   Pogonka, Thomas ^c  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 5; MICROORGANISM PROTEIN; RECOMBINANT PROTEIN;

ARTICLE; BLINDNESS; CONTROLLED STUDY; DERMATITIS; ENDEMIC DISEASE; HUMAN; HUMAN CELL; INFLAMMATION; MONONUCLEAR CELL; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PRIORITY JOURNAL;

EID: 0030800092     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517317     Document Type: Article

References (17)

1. Ottesen EA. Immune responsiveness and the pathogenesis of human onchocerciasis. J Infect Dis 1995;171:659-71.
2. Brattig NW, Tischendorf FW, Albiez EJ, Büttner DW, Berger J. Distribution pattern of peripheral lymphocyte subsets in localized and generalized form of onchocerciasis. Clin Immunol Immunopathol 1987;44:149-59.
3. Brattig NW, Krawietz I, Abakar AZ, Erttmann KD, Kruppa TF, Massougbodji A. Strong IgG isotypic antibody response in sowdah type onchocerciasis. J Infect Dis 1994;170:955-61.
4. Rubio de Krömer MT, Medina-De la Garza CE, Brattig NW. Differences in eosinophil and neutrophil chemotactic responses in sowdah and generalized form of onchocerciasis. Acta Tropica 1995;60:21-33.
5. Ward DJ, Nutman TB, Zea-Flores G, Protocarrero C, Lujan A, Ottesen EA. Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals. J Infect Dis 1988;157:536-43.
6. Elson LH, Calvopina-H M, Paredes-Y W, et al. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. J Infect Dis 1995;171:652-8.
7. Lange AM, Yutanawiboonchai W, Scott P, Abraham D. IL-4- and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice. J Immunol 1994;153:205-11.
8. Lucius R, Erondu N, Kern A, Donelson JE. Molecular cloning of an immunodominant antigen of Onchocerca volvulus. J Exp Med 1988;168:1199-204.
9. Seeber F, Brattig NW, Soboslay PT, et al. Characterization of a recombinant T cell and B cell reactive polypeptide of Onchocerca volvulus. J Immunol 1993;150:2931-44.
10. 9a.Pogonka T, Brattig NW, Nde PN, et al. Localization of T and B cell stimulating domains of the immunodominant 33 kDa protein of Onchocerca volvulus (Ov33). Clin Immunol Immunopathol 1997 (in press).
11. Stüber D, Matile H, Garotta G. System for high-level production in Escherichia coli and rapid purification of recombinant proteins: application to epitope mapping, preparation of antibodies, and structure-function analysis. In: Lefkovits I, Pernis B, eds. Immunological methods. Vol 4. Orlando, FL: Academic Press, 1990:121-52.
12. Steel C, Nutman TB. Regulation of IL-5 in onchocerciasis. A critical role for IL-2. J Immunol 1993;150:5511-8.
13. Plier DA, Awadzi K, Freedman DO. Immunoregulation in onchocerciasis: persons with ocular inflammatory disease produce a Th2-like response to Onchocerca volvulus antigen. J Infect Dis 1996;174:380-6.
14. Steel C, Guinea A, Ottesen EA. Evidence for protective immunity to Bancroftian filariasis in the Cook Islands. J Infect Dis 1996;174:598-605.
15. Gallin M, Edmonds K, Ellner JJ, et al. Cell-mediated immune responses in human infection with Onchocerca volvulus. J Immunol 1988;140:1999-2007.
16. Buettner DW, Rácz P. Macro- and microfilariae in nodules from onchocerciasis patients in the Yemen Arab Republic. Trop Med Parasitol 1983;34:113-21.
17. Garraud O, Nkenfou C, Bradley JE, Perler FB, Nutman TB. Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies. J Immunol 1995;155:1316-25.